• Explore /
  • Poster
  • / IND candidate EPI-7386 as an N-terminal domain androgen receptor inhibitor in development for the treatment of prostate cancer.

IND candidate EPI-7386 as an N-terminal domain androgen receptor inhibitor in development for the treatment of prostate cancer.

Abstract Poster

Authors

null

Ronan Le Moigne

ESSA Pharmaceuticals, Inc., Houston, TX

Ronan Le Moigne , C. Adriana Banuelos , Nasrin R. Mawji , Teresa Tam , Jun Wang , Kunzhong Jian , Raymond J. Andersen , Alessandra Cesano , Marianne Sadar , Han-Jie Zhou , Peter Virsik

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 142)

Abstract #

142

Poster Bd #

F22

Abstract Disclosures

Similar Posters

First Author: Xiaolin Zhu

First Author: Evan Y. Yu

First Author: Andrew J. Armstrong

First Author: Aishwarya Subramanian